Merck & Co., through its subsidiary MSD Netherlands Capital B.V., has announced the pricing of a series of notes with varying interest rates and maturities. The notes, which are expected to be rated A1 by Moody's and A+ by S&P, will be issued in denominations of €850,000,000 each, with maturity dates ranging from 2032 to 2054 and annual coupons between 3.250% and 3.750%. The trade date is set for May 16, 2024, with a settlement date of May 30, 2024. The notes will be listed on the NYSE and governed by the laws of the State of New York. Joint Book-Running Managers for the offering include Citigroup Global Markets Europe AG, BNP Paribas, and Deutsche Bank Aktiengesellschaft, among others. The offering is SEC Registered and the notes will be redeemable before their respective maturity dates under certain conditions. The pricing term sheet is supplementary to the preliminary prospectus supplement issued by MSD Netherlands Capital B.V. on May 15, 2024.

Merck & Co., through its subsidiary MSD Netherlands Capital B.V., has announced the pricing of a series of notes with varying interest rates and maturities. The notes, which are expected to be rated A1 by Moody's and A+ by S&P, will be issued in denominations of €850,000,000 each, with maturity dates ranging from 2032 to 2054 and annual coupons between 3.250% and 3.750%. The trade date is set for May 16, 2024, with a settlement date of May 30, 2024. The notes will be listed on the NYSE and governed by the laws of the State of New York. Joint Book-Running Managers for the offering include Citigroup Global Markets Europe AG, BNP Paribas, and Deutsche Bank Aktiengesellschaft, among others. The offering is SEC Registered and the notes will be redeemable before their respective maturity dates under certain conditions. The pricing term sheet is supplementary to the preliminary prospectus supplement issued by MSD Netherlands Capital B.V. on May 15, 2024.